HealthDay - THURSDAY, March 11 (HealthDay News) -- The recent approval of a new, more broadly effective pneumococcal vaccine (PCV13) for young children could greatly reduce the prevalence of pneumococcal disease in that age group, a new government report suggests.
HealthDay - THURSDAY, March 11 (HealthDay News) -- A mutation that affects how the body responds when a person smells or tastes food may play a role in the development of type 2 diabetes in some people, U.S. researchers report.
HealthDay - THURSDAY, March 11 (HealthDay News) -- Obesity plus daily drinking boosts the risk of liver disease in men and women, researchers report in two new studies.
Allowing women to collect their own cervicovaginal lavage specimens for human papillomavirus (HPV) testing increased coverage and cervical abnormality detection rates in a community-based cervical cancer screening program, Dutch researchers said.
Blood pressure variability over time, not merely its average level, is a powerful risk factor for stroke, myocardial infarction, and other cardiovascular events, researchers said.
Reuters - Women who gain weight too quickly during the first three months of pregnancy are more prone to develop pregnancy-related diabetes, new research shows.
Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that the Applicant Janssen-Cilag International NV (Janssen- Cilag), a Johnson & Johnson company, has submitted a request for re-examination of the negative opinion by the European Committee for Medicinal Products for Human Use (CHMP) on the Marketing Authorization Application (MAA) for ceftobiprole for the treatment of complicated skin and soft tissue infections (cSSTI). On February 18, 2010, the CHMP adopted a negative opinion on the MAA for ceftobiprole for the treatment of cSSTI...